Medical doctor, specialized in tropical medicine, emergency medicine and epidemiology. In 1989 he went on mission with Médecins sans Frontières for the first time, and undertook long-term missions in Uganda, Somalia and Thailand. He returned to the Paris headquarters in 1994 as a programs director. Between 1996 and 1998, he served as the director of communications, and later as director of operations until May 2000 when he was elected president of the French section of Médecins sans Frontières. He was re-elected in May 2003 and in May 2006. From 2000 to 2008, he was a member of the International Council of MSF and a member of the Board of MSF USA. He is the co-editor of "Medical innovations in humanitarian situations" (MSF, 2009) and Humanitarian Aid, Genocide and Mass Killings: Médecins Sans Frontiéres, The Rwandan Experience, 1982–97 (Manchester University Press, 2017).
If MSF has held a preponderant position in the response to the Ebola crisis, it owes it just as much to its intervention capacities as to its capacity for criticism. The following article by Jean-Hervé Bradol embodies perfectly the latter in pointing to the issues that appeared on the occasion of this epidemic.
How to intervene with the civilian populations in the middle of the war in Syria? Jean-Hervé Bradol, director of studies at Crash and former project coordinator for the northern part of Syria in 2013, testifies about the negotiations carried out in Syria in cities taken by groups affiliated to Al Qaeda or the Islamic State. This article was published on the Mediapart website on February 1, 2015.
The Drugs for Neglected Diseases initiative (DNDi) and other researchers, including MSF-Crash Dr. Jean Hervé Bradol, report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts.
Jean-Hervé Bradol has just returned from an exploratory mission in northern Syria. He is interviewed by La Croix.
Epidemiological studies estimate that nearly nine million people were suffering from active tuberculosis (TB) in 2010, causing upwards of one and a half million deaths. More than 90% of these deaths took place in low- or middle-income countries, thus reinforcing an old idea that TB and poverty are strongly linked.
It seemed appropriate to assemble these texts now, at a time when the history of our AIDS missions is compelling us to formulate new goals.
Medical Innovations in Humanitarian Situations explores how the particular style of humanitarian action practiced by MSF has stayed in line with the standards in scientifically advanced countries while also leading to significant improvements in the medical care delivered to people in crisis.
For the past several months, news about food shortages and famines affecting large segments of the East African population have been fueling donation appeals from major public and private aid organizations.